Literature DB >> 19653353

Bell's palsy and choreiform movements during peginterferon alpha and ribavirin therapy.

Sener Barut1, Hatice Karaer, Erol Oksuz, Asli Gündoğdu Eken, Ayse Nazli Basak.   

Abstract

Neuropsychiatric side effects of long-term recombinant interferon-alpha therapy consist of a large spectrum of symptoms. In the literature, cranial neuropathy, especially Bell's palsy, and movement disorders, have been reported much less often than other neurotoxic effects. We report a case of Bell's palsy in a patient with chronic hepatitis C during peginterferon-alpha and ribavirin therapy. The patient subsequently developed clinically inapparent facial nerve involvement on the contralateral side and showed an increase in choreic movements related to Huntington's disease during treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653353      PMCID: PMC2721249          DOI: 10.3748/wjg.15.3694

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Recombinant interferon-alpha-induced chorea and frontal subcortical dementia.

Authors:  Antoine Moulignier; Stephanie Allo; Robert Zittoun; Oliver Gout
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

2.  Development of chorea with lupus anticoagulant after interferon therapy.

Authors:  J P Neau; F Guilhot; C Boinot; P Dumas; A M Tantot; R Gil
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

3.  Facial nerve grading system.

Authors:  J W House; D E Brackmann
Journal:  Otolaryngol Head Neck Surg       Date:  1985-04       Impact factor: 3.497

4.  Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell's palsy).

Authors:  O Abramsky; C Webb; D Teitelbaum; R Arnon
Journal:  J Neurol Sci       Date:  1975-09       Impact factor: 3.181

5.  Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa.

Authors:  S Hayasaka; M Fujii; Y Yamamoto; S Noda; H Kurome; M Sasaki
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

6.  A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

Authors:  G Fattovich; G Giustina; S Favarato; A Ruol
Journal:  J Hepatol       Date:  1996-01       Impact factor: 25.083

7.  A survey of facial paralysis: etiology and incidence.

Authors:  J N Bleicher; S Hamiel; J S Gengler; J Antimarino
Journal:  Ear Nose Throat J       Date:  1996-06       Impact factor: 1.697

8.  Retinal complications during interferon therapy for chronic hepatitis C.

Authors:  T Kawano; M Shigehira; H Uto; T Nakama; J Kato; K Hayashi; T Maruyama; T Kuribayashi; T Chuman; T Futami; H Tsubouchi
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

Review 9.  Facial palsy and infection: the unfolding story.

Authors:  M Morgan; D Nathwani
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

10.  Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

Authors:  G B Gaeta; D F Precone; F M Felaco; R Bruno; A Spadaro; G Stornaiuolo; M Stanzione; T Ascione; R De Sena; A Campanone; G Filice; F Piccinino
Journal:  Aliment Pharmacol Ther       Date:  2002-09       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.